Cargando…

In vivo Validation of Bimolecular Fluorescence Complementation (BiFC) to Investigate Aggregate Formation in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic lateral sclerosis (ALS) is a form of motor neuron disease (MND) that is characterized by the progressive loss of motor neurons within the spinal cord, brainstem, and motor cortex. Although ALS clinically manifests as a heterogeneous disease, with varying disease onset and survival, a uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Don, Emily K., Maschirow, Alina, Radford, Rowan A. W., Scherer, Natalie M., Vidal-Itriago, Andrés, Hogan, Alison, Maurel, Cindy, Formella, Isabel, Stoddart, Jack J., Hall, Thomas E., Lee, Albert, Shi, Bingyang, Cole, Nicholas J., Laird, Angela S., Badrock, Andrew P., Chung, Roger S., Morsch, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018926/
https://www.ncbi.nlm.nih.gov/pubmed/33415684
http://dx.doi.org/10.1007/s12035-020-02238-0
_version_ 1783674276642029568
author Don, Emily K.
Maschirow, Alina
Radford, Rowan A. W.
Scherer, Natalie M.
Vidal-Itriago, Andrés
Hogan, Alison
Maurel, Cindy
Formella, Isabel
Stoddart, Jack J.
Hall, Thomas E.
Lee, Albert
Shi, Bingyang
Cole, Nicholas J.
Laird, Angela S.
Badrock, Andrew P.
Chung, Roger S.
Morsch, Marco
author_facet Don, Emily K.
Maschirow, Alina
Radford, Rowan A. W.
Scherer, Natalie M.
Vidal-Itriago, Andrés
Hogan, Alison
Maurel, Cindy
Formella, Isabel
Stoddart, Jack J.
Hall, Thomas E.
Lee, Albert
Shi, Bingyang
Cole, Nicholas J.
Laird, Angela S.
Badrock, Andrew P.
Chung, Roger S.
Morsch, Marco
author_sort Don, Emily K.
collection PubMed
description Amyotrophic lateral sclerosis (ALS) is a form of motor neuron disease (MND) that is characterized by the progressive loss of motor neurons within the spinal cord, brainstem, and motor cortex. Although ALS clinically manifests as a heterogeneous disease, with varying disease onset and survival, a unifying feature is the presence of ubiquitinated cytoplasmic protein inclusion aggregates containing TDP-43. However, the precise mechanisms linking protein inclusions and aggregation to neuronal loss are currently poorly understood. Bimolecular fluorescence complementation (BiFC) takes advantage of the association of fluorophore fragments (non-fluorescent on their own) that are attached to an aggregation-prone protein of interest. Interaction of the proteins of interest allows for the fluorescent reporter protein to fold into its native state and emit a fluorescent signal. Here, we combined the power of BiFC with the advantages of the zebrafish system to validate, optimize, and visualize the formation of ALS-linked aggregates in real time in a vertebrate model. We further provide in vivo validation of the selectivity of this technique and demonstrate reduced spontaneous self-assembly of the non-fluorescent fragments in vivo by introducing a fluorophore mutation. Additionally, we report preliminary findings on the dynamic aggregation of the ALS-linked hallmark proteins Fus and TDP-43 in their corresponding nuclear and cytoplasmic compartments using BiFC. Overall, our data demonstrates the suitability of this BiFC approach to study and characterize ALS-linked aggregate formation in vivo. Importantly, the same principle can be applied in the context of other neurodegenerative diseases and has therefore critical implications to advance our understanding of pathologies that underlie aberrant protein aggregation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12035-020-02238-0.
format Online
Article
Text
id pubmed-8018926
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-80189262021-04-16 In vivo Validation of Bimolecular Fluorescence Complementation (BiFC) to Investigate Aggregate Formation in Amyotrophic Lateral Sclerosis (ALS) Don, Emily K. Maschirow, Alina Radford, Rowan A. W. Scherer, Natalie M. Vidal-Itriago, Andrés Hogan, Alison Maurel, Cindy Formella, Isabel Stoddart, Jack J. Hall, Thomas E. Lee, Albert Shi, Bingyang Cole, Nicholas J. Laird, Angela S. Badrock, Andrew P. Chung, Roger S. Morsch, Marco Mol Neurobiol Article Amyotrophic lateral sclerosis (ALS) is a form of motor neuron disease (MND) that is characterized by the progressive loss of motor neurons within the spinal cord, brainstem, and motor cortex. Although ALS clinically manifests as a heterogeneous disease, with varying disease onset and survival, a unifying feature is the presence of ubiquitinated cytoplasmic protein inclusion aggregates containing TDP-43. However, the precise mechanisms linking protein inclusions and aggregation to neuronal loss are currently poorly understood. Bimolecular fluorescence complementation (BiFC) takes advantage of the association of fluorophore fragments (non-fluorescent on their own) that are attached to an aggregation-prone protein of interest. Interaction of the proteins of interest allows for the fluorescent reporter protein to fold into its native state and emit a fluorescent signal. Here, we combined the power of BiFC with the advantages of the zebrafish system to validate, optimize, and visualize the formation of ALS-linked aggregates in real time in a vertebrate model. We further provide in vivo validation of the selectivity of this technique and demonstrate reduced spontaneous self-assembly of the non-fluorescent fragments in vivo by introducing a fluorophore mutation. Additionally, we report preliminary findings on the dynamic aggregation of the ALS-linked hallmark proteins Fus and TDP-43 in their corresponding nuclear and cytoplasmic compartments using BiFC. Overall, our data demonstrates the suitability of this BiFC approach to study and characterize ALS-linked aggregate formation in vivo. Importantly, the same principle can be applied in the context of other neurodegenerative diseases and has therefore critical implications to advance our understanding of pathologies that underlie aberrant protein aggregation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12035-020-02238-0. Springer US 2021-01-07 2021 /pmc/articles/PMC8018926/ /pubmed/33415684 http://dx.doi.org/10.1007/s12035-020-02238-0 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Don, Emily K.
Maschirow, Alina
Radford, Rowan A. W.
Scherer, Natalie M.
Vidal-Itriago, Andrés
Hogan, Alison
Maurel, Cindy
Formella, Isabel
Stoddart, Jack J.
Hall, Thomas E.
Lee, Albert
Shi, Bingyang
Cole, Nicholas J.
Laird, Angela S.
Badrock, Andrew P.
Chung, Roger S.
Morsch, Marco
In vivo Validation of Bimolecular Fluorescence Complementation (BiFC) to Investigate Aggregate Formation in Amyotrophic Lateral Sclerosis (ALS)
title In vivo Validation of Bimolecular Fluorescence Complementation (BiFC) to Investigate Aggregate Formation in Amyotrophic Lateral Sclerosis (ALS)
title_full In vivo Validation of Bimolecular Fluorescence Complementation (BiFC) to Investigate Aggregate Formation in Amyotrophic Lateral Sclerosis (ALS)
title_fullStr In vivo Validation of Bimolecular Fluorescence Complementation (BiFC) to Investigate Aggregate Formation in Amyotrophic Lateral Sclerosis (ALS)
title_full_unstemmed In vivo Validation of Bimolecular Fluorescence Complementation (BiFC) to Investigate Aggregate Formation in Amyotrophic Lateral Sclerosis (ALS)
title_short In vivo Validation of Bimolecular Fluorescence Complementation (BiFC) to Investigate Aggregate Formation in Amyotrophic Lateral Sclerosis (ALS)
title_sort in vivo validation of bimolecular fluorescence complementation (bifc) to investigate aggregate formation in amyotrophic lateral sclerosis (als)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018926/
https://www.ncbi.nlm.nih.gov/pubmed/33415684
http://dx.doi.org/10.1007/s12035-020-02238-0
work_keys_str_mv AT donemilyk invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT maschirowalina invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT radfordrowanaw invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT scherernataliem invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT vidalitriagoandres invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT hoganalison invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT maurelcindy invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT formellaisabel invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT stoddartjackj invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT hallthomase invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT leealbert invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT shibingyang invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT colenicholasj invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT lairdangelas invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT badrockandrewp invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT chungrogers invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals
AT morschmarco invivovalidationofbimolecularfluorescencecomplementationbifctoinvestigateaggregateformationinamyotrophiclateralsclerosisals